- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ImmuCell Corporation (ICCC)
Assess today's live ImmuCell Corporation (ICCC) share price, performance and insights using our live NASDAQ: ICCC stock exchange data.
Analyse the historical data and ImmuCell Corporation share price performance charts on this page. Our technical summary section provides analysis on ImmuCell share price buy/sell indicators using real-time data (or discuss the ImmuCell (ICCC) stock price today with other investors in the ImmuCell NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ICCC share price (ISIN: US4525253062) to enhance your trading decisions with our free investment tools and resources.
What Is the ImmuCell Corporation Share Price Today?
The ImmuCell share price today is 7.720.
What Is the Stock Symbol for ImmuCell Corporation
The stock symbol (or 'ticker') for ImmuCell Corporation is "ICCC."
What Stock Exchange Does ImmuCell Corporation Trade On?
ImmuCell Corporation is listed and trades on the NASDAQ stock exchange.
Is ImmuCell Corporation a Good Stock to Buy?
Determining whether ImmuCell Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and ImmuCell Corporation share price performance charts on this page. Our technical summary section provides analysis on ImmuCell share price buy/sell indicators using real-time data (or discuss the ImmuCell (ICCC) stock price today with other investors in the ImmuCell NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ICCC share price (ISIN: US4525253062) to enhance your trading decisions with our free investment tools and resources.
What Is the ImmuCell Corporation Share Price Today?
The ImmuCell share price today is 7.720.
What Is the Stock Symbol for ImmuCell Corporation
The stock symbol (or 'ticker') for ImmuCell Corporation is "ICCC."
What Stock Exchange Does ImmuCell Corporation Trade On?
ImmuCell Corporation is listed and trades on the NASDAQ stock exchange.
Is ImmuCell Corporation a Good Stock to Buy?
Determining whether ImmuCell Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.700
7.990
52 wk Range
4.520
8.230
ICCC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.7007.990
52 wk Range
4.5208.230
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ICCC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
- ImmuCell appoints Kathy Turner to board of directors
- Investing.com
- ImmuCell reports 28% sales increase in first quarter
- Investing.com
- ImmuCell reports 28% sales increase in first quarter
- Investing.com
- Form 8K ImmuCell Corporation For: 8 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
ImmuCell Corporation Earnings Call Summary for Q4/2025
- ImmuCell posted Q4 2025 net loss of $0.31/share on $7.63M revenue, down 1.6% quarterly; full-year sales grew 4.3% year-over-year.
- Net operating profit reached $1.6M in 2025, marking $3.3M improvement from 2024; gross margin expanded to 41% from 30% prior year.
- Domestic sales surged 8.7% in Q4, offsetting international weakness driven by Canadian order timing volatility and market challenges.
- Company executing strategic pivot away from Re-Tain to concentrate resources on First Defense product line and market expansion.
- Management targets 5-6M unit annual manufacturing capacity without major capex; focus on yield improvements and operational efficiency gains.
Last Updated: 05/03/2026, 14:58
Read Full TranscriptCompare ICCC to Peers and Sector
Metrics to compare | ICCC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipICCCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −67.2x | −3.3x | −0.4x | |
PEG Ratio | −1.28 | −0.09 | 0.00 | |
Price/Book | 2.6x | 3.9x | 2.6x | |
Price / LTM Sales | 2.5x | 48.5x | 3.2x | |
Upside (Analyst Target) | - | 68.6% | 45.4% | |
Fair Value Upside | Unlock | 10.3% | 7.0% | Unlock |
Earnings
Latest Release
04/03/2026
EPS / Forecast
-0.31 / --
Revenue / Forecast
7.63K / --
People Also Watch
FAQ
What Is the ImmuCell (ICCC) Share Price Today?
The ImmuCell stock price today is 7.720 USD.
What Stock Exchange Does ImmuCell (ICCC) Trade On?
ImmuCell is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for ImmuCell?
The stock symbol (also called a 'ticker') for ImmuCell is "ICCC."
What Is the Current ImmuCell Market Cap?
As of today, ImmuCell market cap is 69.840M USD.
What Is ImmuCell's (ICCC) Earnings Per Share (TTM)?
The ImmuCell EPS is currently -0.120 (Trailing Twelve Months).
When Is the Next ImmuCell Earnings Date?
ImmuCell's next earnings report will be released on 14/05/2026.
Is ICCC a Buy or Sell From a Technical Analyst Perspective?
Based on today's ImmuCell moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has ImmuCell Stock Split?
ImmuCell has split 1 times. (See the ICCC stock split history page for full effective split date and price information.)
How Many Employees Does ImmuCell Have?
ImmuCell has 73 employees.
What is the current trading status of ImmuCell (ICCC)?
As of 22/04/2026, ImmuCell (ICCC) is trading at a price of 7.720 USD, with a previous close of 8.020 USD. The stock has fluctuated within a day range of 7.700 USD to 7.990 USD, while its 52-week range spans from 4.520 USD to 8.230 USD.
What Is the ICCC Premarket Price?
ICCC's last pre-market stock price is 8.000 USD. The pre-market share volume is 20.000, and the stock has decreased by -0.020, or -0.250%.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.